Exam 5 Deck 8 Flashcards
Drug to promote cellular growth
Somatotropin
Drug to reduce growth hormone
Octreotide
AE: somatotropin
Hyperglycemia
AE Octrotide
Glucose dysregulation, GI upset
Drug for reabsorbing water
Desmopressin
Indication for Desmopressin
Diabetes insipidus, bed wetting (von willlerbrand’s)
Indications for Octreotide
Tumor with growth hormone, other excessive GH
AE of Desmopressin
Hyponateriam
(Water dilution inside
Drug for thyroid hormone replacement
Levothyroxine
Treats hypothyroidism
Can cause hyperthyroidsim
Indication to increase dose of levothyroxine
Elevated TSH
Contra Indication for levothyroxine
Cardiovascular disease
Drug to lower thyroid activity (Treat Grave’s disease)
Methimazole
CI for methimazole
Immunocompromised
Indication for Propythiouracil
Hyperthyroidism
How Propylthiouracil prevents Thyroid stimulations
Prevents Iodine from being active
Drugs to treat addisons disease
Hydrocortisone and Fludrocortisone
MOA and AE of hydrocortisone
MOA: Gucocorticoid
AE: Cushing’s syndrome, Infection, glucose intolerance, osteoporosis, adrenal suppression, peptic ulcers
MOA of fludrocortisone
Mineralcorticoid: promotes Na+ reabsorption
K+ and H+ excretion
S/S of hypoglycemia
Sweating
Pallor
Hunger
Irritability
Lack of coordination
Sleepy
(Hangry)
S/S of hyperglycemai
(Dry)
Dry mouth
Thirst
Headache
Blurred vision
Frequent urination
Weakness
Normal range for serum glucose
70-110 mg/dL
Test to measure 3 month glucose level
HbA1C
LeARNinG(D)
Pneumonic
Rapid acting
Lispro, Aspart
Short acting
Regular (clear)
Intermediate acting
NPH
Long acting Gargine, Detemir
Onset for rapid acting insulin (Lispro, Aspart)
15-30 min
Onset short acting insulin (Regular)
30-60 minutes
Onset for intermediate acting insulin (NPH)
60-120 min
Onset for long acting insulin (Glargine, Detemir)
70 min
Peak effect for rapid acting insulin (lispro, aspart)
30 min - 2.5 hrs
Peak affect for short acting insulin (regular)
1-5 hrs
Peak effect for intermediate acting insulin (NPH)
6-14 hrs
Peak effect for long acting insulin (glargine, determir)
None
Duration of action for rapid acting insulin (lispro, aspart)
3-6 hrs
Duration of action of short acting insulin (regular)
6-10 hrs
Duration of action for intermediate acting insulin (NPH)
16-24 hrs
Duration of action for long acting insulin (Glargine, detemir)
18-24 hrs
When to use rapid acting insulin (lispro, aspart)
Meals or acute hyperglycemia
When to use short acting insulin (regular)
Meals/acute hyperglycemia
When to use intermediate insulin (NPH)
Basal levels
When to use long-acting insulin (Glargine, Detemir)
Basal insulin
Drugs to use in Type II diabetes mellitus
Glyburide/glipizide
Repaglinide
Acarbose
Canagliflozin
Metformin
When to use glucagon
Hypoglycemia, emergency treatment
Treatments for Type II DM that can cause hypoglycemia
Repaglinide
Glyburide/glipizide
Type II DM meds that do not cause Hypoglycemia
Metformin
Acarbose
Canagliflozin
Pramlintide
Treatment options for Type I DM
Insulin
MOA of met formin
Increases glucose uptake through increasing insulin sensitivity
Adverse effects of metformin
Lactic acidosis
GI upset, VB12 and folate deficiency
MOA of glyburide and Repaglinide
Stimulates the pancreas to release insulin
MOA and AE for Acarbose
MOA: Slows carbohydrate absorption
AE: GI upset
MOA and AE of Canagliflozin
MOA: Causes kidney to excrete glucose
AE: Cystitis, candidiasis, polyuria, hypotension (Increased glucose in urine= more infection)